Dr Reddy’s Laboratories launches Icosapent Ethyl Capsules in US
Dr Reddy’s Laboratories yesterday launched Icosapent Ethyl capsules, used to reduce triglyceride (TG) levels in adult patients, in the US market.
The company has launched the capsules in one gram strength after approval by the US Food and Drug Administration (USFDA), the company said in a regulatory filing.
Dr Reddy’s Icosapent Ethyl is available in one gram capsules in a bottle count size of 120’s count. It is approved as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe hypertriglyceridemia.
Recent Posts
Mounjaro Launched in India: Price & Impact on Diabetes and Obesity
Eli Lilly, a leading American pharmaceutical company, has launched its groundbreaking diabetes and obesity medication,…
Shocking Rabies Case in Greater Noida Challenges Common Misconceptions
A recent case of rabies transmission in Greater Noida has sent shockwaves through the community,…
Punjab Government to Ban Energy Drinks in Schools and Colleges for Student Health
The Punjab government is set to ban high-caffeine energy drinks in schools, citing severe health…
Experts Warn of Global Threat from Chronic Wasting Disease
Chronic Wasting Disease (CWD) is a highly contagious and fatal neurological disorder that affects deer,…
CDC Reschedules Vaccine Advisory Meeting to April 15-16
The Centers for Disease Control and Prevention (CDC) has announced a rescheduling of its vaccine…
India’s Specialty Chemicals Rebound, Pharma Exports Surge
India’s specialty chemicals industry and pharmaceutical exports continue to showcase resilience amid global uncertainties. As…